Mcrae Capital Management Inc Vertex Pharmaceuticals Inc Transaction History
Mcrae Capital Management Inc
- $444 Million
- Q1 2025
A detailed history of Mcrae Capital Management Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Mcrae Capital Management Inc holds 30,328 shares of VRTX stock, worth $13.7 Million. This represents 3.31% of its overall portfolio holdings.
Number of Shares
30,328
Previous 31,078
2.41%
Holding current value
$13.7 Million
Previous $12.5 Million
17.48%
% of portfolio
3.31%
Previous 2.6%
Shares
13 transactions
Others Institutions Holding VRTX
# of Institutions
1,833Shares Held
233MCall Options Held
1.38MPut Options Held
1.08M-
Capital World Investors Los Angeles, CA28.5MShares$12.9 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$10.6 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.61 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.55 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.32 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $116B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...